L2L Microarray Analysis Tool
Results for L01C.profile.ud50
| Results summary | View all lists in GO:BiolProc | View all genes in L01C.profile.ud50 |
| List Name | Description | Total probes |
Expected matches |
Actual matches |
Fold Enrichment |
Binomial p-value |
|---|---|---|---|---|---|---|
| natural killer cell mediated immunity | The promotion of an immune response by natural killer cells through direct recognition of target cells or through the release of cytokines. | 18 | 0.09 | 4 | 44.95 | 1.73e-06 |
| natural killer cell mediated cytotoxicity | The directed killing of a target cell by a natural killer cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors. | 18 | 0.09 | 4 | 44.95 | 1.73e-06 |
| leukocyte mediated cytotoxicity | The directed killing of a target cell by a leukocyte. | 21 | 0.10 | 4 | 38.53 | 3.34e-06 |
| cell killing | Any process in an organism that results in the killing of its own cells or those of another organism, including in some cases the death of the other organism. Killing here refers to the induction of death in one cell by another cell, not cell-autonomous death due to internal or other environmental conditions. | 26 | 0.13 | 4 | 31.12 | 8.19e-06 |
| microtubule-based movement | Movement of organelles, other microtubules and other particles along microtubules, mediated by motor proteins. | 110 | 0.54 | 6 | 11.03 | 2.02e-05 |
| protein polymerization | The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein. | 82 | 0.41 | 5 | 12.33 | 5.87e-05 |
| cytoskeleton-dependent intracellular transport | The directed movement of substances along cytoskeletal elements such as microfilaments or microtubules within a cell. | 139 | 0.69 | 6 | 8.73 | 7.48e-05 |
| immune effector process | Any process of the immune system that occurs as part of an immune response. | 143 | 0.71 | 5 | 7.07 | 7.79e-04 |
| positive regulation of apoptosis | Any process that activates or increases the frequency, rate or extent of cell death by apoptosis. | 396 | 1.96 | 8 | 4.09 | 9.21e-04 |
| positive regulation of programmed cell death | Any process that activates or increases the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes. | 400 | 1.98 | 8 | 4.05 | 9.82e-04 |
| organelle organization and biogenesis | A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of any organelle within a cell. | 1437 | 7.10 | 17 | 2.39 | 1.08e-03 |
| microtubule-based process | Any cellular process that depends upon or alters the microtubule cytoskeleton, that part of the cytoskeleton comprising microtubules and their associated proteins. | 237 | 1.17 | 6 | 5.12 | 1.28e-03 |
| innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. | 97 | 0.48 | 4 | 8.34 | 1.44e-03 |
| induction of apoptosis | A process that directly activates any of the steps required for cell death by apoptosis. | 341 | 1.69 | 7 | 4.15 | 1.73e-03 |
| induction of programmed cell death | A process which directly activates any of the steps required for programmed cell death. | 343 | 1.70 | 7 | 4.13 | 1.79e-03 |
| lymphocyte mediated immunity | Any process involved in the carrying out of an immune response by a lymphocyte. | 116 | 0.57 | 4 | 6.97 | 2.76e-03 |
| leukocyte mediated immunity | Any process involved in the carrying out of an immune response by a leukocyte. | 124 | 0.61 | 4 | 6.52 | 3.50e-03 |
| lactation | The secretion of milk by the mammary gland. | 24 | 0.12 | 2 | 16.86 | 6.28e-03 |
| cytoskeleton organization and biogenesis | A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures. | 661 | 3.27 | 9 | 2.75 | 6.37e-03 |
| regulation of apoptosis | Any process that modulates the occurrence or rate of cell death by apoptosis. | 785 | 3.88 | 10 | 2.58 | 6.53e-03 |
| cell cycle | The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division. | 1307 | 6.46 | 14 | 2.17 | 6.63e-03 |
| regulation of programmed cell death | Any process that modulates the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes. | 793 | 3.92 | 10 | 2.55 | 6.98e-03 |
| apoptosis | A form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases, whose actions dismantle the cell and result in cell death. Apoptosis begins internally with condensation and subsequent fragmentation of the cell nucleus (blebbing) while the plasma membrane remains intact. Other characteristics of apoptosis include DNA fragmentation and the exposure of phosphatidyl serine on the cell surface. | 1078 | 5.33 | 12 | 2.25 | 8.59e-03 |
| programmed cell death | Cell death resulting from activation of endogenous cellular processes. | 1086 | 5.37 | 12 | 2.24 | 9.07e-03 |